SCHEMBL2473909

SCHEMBL2473909

C=CCN(CC=C)CCc1ccc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 3/20 0.49
HDAC8 Q9BY41 3/20 0.49
HDAC3 O15379 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC2 Q92769 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
FFAR4 Q5NUL3 2/20 0.47
MAPT P10636 2/20 0.46
SERPINE1 P05121 1/20 0.46
TP53 P04637 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
KCNH2 Q12809 1/20 0.43
RORC P51449 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4919634 0.99 HDAC1 (0.48) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL5334365 0.88 HDAC1 (0.51) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL2472519 0.83 HDAC1 (0.50) HDAC1HDAC8HDAC3HDAC4HDAC7
SCHEMBL1717947 0.83 SLC6A4 (0.41) SERPINE1
SCHEMBL2473984 0.83 ADRB3 (0.50) HDAC1HDAC8HDAC3HDAC4HDAC7
Hydrochloric Acid SCHEMBL4922816 0.83 HDAC1 (0.49) HDAC1HDAC8HDAC3HDAC4HDAC7
Hydrochloric Acid SCHEMBL4919607 0.82 MMP2 (0.40) SERPINE1
SCHEMBL2470985 0.79 ALDH1A1 (0.50) FFAR4MAPTSMN1; SMN2DRD2DRD3
Hydrochloric Acid SCHEMBL4920272 0.78 ALDH1A1 (0.49) FFAR4MAPTSMN1; SMN2DRD2DRD3
Propane SCHEMBL7208561 0.76 HTR6 (0.58) HDAC1HDAC8HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2371814-A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor Abbott GmbH & Co. KG (DE) 2011-10-05 EP disclosed